References: Professor H.C. Ashton:submission to Health Committee 1999 - (6th report).

1. Petursson H.& Lader M.,H:British Journal of Addiction,(1981) 76,133-45.


2. Owen R.,T. & Tyrer P:Drugs (1993)25, 385-98.


3. Ashton H. & Golding J., F. :British Journal of Addiction 84,541-6.


4. Ashton H.:British Medical Journal (1984) 288,1135-40.


5. Hallstrom C. & Lader M.,H.:Pharmacopsychiatry (1981) 16, 235-44.


6. Dupont R., L. &Saylor K.,E.:in Clinical Textbook of Addictive Disorders,N.Y., Guildford Press,(1991),69-102.


7. Tyrer P: Stress Medicine(1991)7, 1-2.


8. Ashton H.:Journal of Substance Abuse Treatment(1991)8, 10-28.


9. Ashton H. Psychiatric Annals,(1995) 25,174-9.


10. Committee on Safety of Medicines:Current Problems(1988),21.


11. Royal College of Psychiatrists:Bulletin of Royal College of Psychiatrists(1988)12, 107-8.


12. Heather B.,B: Reducing Long-term benzodiazepine Use. NHS Research Project, 1996-8.


13. Ashton H. in Addiction (1994) 89 1535-41.


14. Ashton H. in Textbook of Adverse Drug Reactions .Oxford University Press (1993) 128-42.


15. Laegried L. et al.Neuripaediatrics (1992) 23, 18-23.


16. Strang J. et al. in Benzodiazepine Dependence.(1993) Oxford Medical Publications (1993)23,128-42


17. Ashton H. inAll You Need to Know About Drink, Drugs and DependenceHarwood Academic Publishers (1999)(in press).


18. Ashton H. Prescribers Journal (1991)1,1-10.